| |
|
|
 |
|
send
print
|
|
|
|
|
Overview: A Window Into the Future
|
|
click to enlarge |
Development risk and attrition rates remain two of the greatest challenges to a successful biopharmaceutical pipeline. To help its customers mitigate both aspects, Lonza launched Applied Protein Services -- a platform of immunogenicity, stability and protein engineering services that provides a window into the future of a biologic. With this capability, the newly integrated Applied Protein Services platform is able to improve the quality, safety, efficacy and manufacturability of antibodies, therapeutic proteins and vaccines.
|
Improve Your Biologic Development Success
|
|
click to enlarge |
The Applied Protein Services platform is effective at improving the quality, safety, efficacy and manufacturability of antibodies, therapeutic proteins, peptides and vaccines. By supporting the successful selection, optimization and early process development of promising drug candidates, Lonza’s Applied Protein Services improves your likelihood of biologic development success.
|
| Applied Protein Services Brochure |
606 Kb |
 |
|
| | |
|
|
|
|
|
|
|
|
 |
;)
;)
